🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
GSK159802 is a potent, inhaled, long acting selective beta-2-receptor agoni...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-08-24
Trial ID
NCT00364273
Treatments Being Tested
The primary objective of this trial was to establish non-inferiority of lun...
Status
Completed
Location
Multiple Locations
Start Date
2005-09
Trial ID
NCT02238106
The objective of this study is to investigate if the systemic drug exposure...
Status
Completed
Location
Multiple Locations
Start Date
2005-09
Trial ID
NCT02254187
Treatments Being Tested
This efficacy and safety study compares four different combinations of blin...
Status
Completed
Location
1249.1.32003 Boehringer Ingelheim Investigational Site
Start Date
2007-10
Trial ID
NCT00535366
Treatments Being Tested
This study will compare the pharmacokinetic (PK) of Fluticasone Propionate/...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-08-05
Trial ID
NCT01890863
The Fluticasone Propionate/Salmeterol combination (FSC) at a dose of 100/50...
Status
Withdrawn
Location
Multiple Locations
Start Date
2014-10
Trial ID
NCT02218762
The purpose of this study is to optimise the device and/or formulation of t...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-01-16
Trial ID
NCT01540708
Treatments Being Tested
Some patients with Chronic Obstructive Pulmonary Disease (COPD) report that...
Status
Completed
Location
Dartmouth-Hitchcock Medical Center
Start Date
2011-07
Trial ID
NCT01391559
Treatments Being Tested
1. To compare the systemic drug exposure of 100 μg Serevent ® Diskus ® with...
Status
Completed
Location
Multiple Locations
Start Date
2004-11
Trial ID
NCT02254226
Treatments Being Tested